Tenon Medical Inc (TNON)
0.85
+0.04
(+4.93%)
USD |
NASDAQ |
May 03, 16:00
0.87
+0.02
(+2.35%)
After-Hours: 20:00
Tenon Medical Research and Development Expense (Quarterly): 0.691M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.691M |
| September 30, 2023 | 0.737M |
| June 30, 2023 | 0.901M |
| March 31, 2023 | 0.834M |
| December 31, 2022 | 0.812M |
| September 30, 2022 | 0.797M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.657M |
| March 31, 2022 | 0.562M |
| December 31, 2021 | 0.793M |
| September 30, 2021 | 0.601M |
| June 30, 2021 | 0.237M |
| March 31, 2021 | 0.087M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.087M
Minimum
Mar 2021
0.901M
Maximum
Jun 2023
0.6424M
Average
0.714M
Median
Research and Development Expense (Quarterly) Benchmarks
| QuidelOrtho Corp | 59.30M |
| Perspective Therapeutics Inc | 6.08M |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |